Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Identifieur interne : 002011 ( Main/Exploration ); précédent : 002010; suivant : 002012Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Auteurs : Giulia Magnani [États-Unis] ; Robert F. Storey [Royaume-Uni] ; Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Marc Cohen [États-Unis] ; Julia Kuder [États-Unis] ; Kyungah Im [États-Unis] ; Philip Aylward [Australie] ; Diego Ardissino [Italie] ; Daniel Isaza [Colombie] ; Alexander Parkhomenko [Ukraine] ; Assen R. Goudev [Bulgarie] ; Mikael Dellborg [Suède] ; Frederic Kontny [Norvège] ; Ramon Corbalan [Chili] ; Felix Medina [Pérou] ; Eva C. Jensen [Suède] ; Peter Held [Suède] ; Eugene Braunwald [États-Unis] ; Marc S. Sabatine [États-Unis] ; Marc P. Bonaca [Serbie]Source :
- European heart journal [ 1522-9645 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Adénosine (administration et posologie), Adénosine (analogues et dérivés), Adénosine (effets indésirables), Antagonistes des récepteurs purinergiques P2Y (administration et posologie), Antagonistes des récepteurs purinergiques P2Y (effets indésirables), Calendrier d'administration des médicaments, Estimation de Kaplan-Meier, Facteurs de risque, Femelle, Humains, Hémorragie (), Infarctus du myocarde (mortalité), Infarctus du myocarde (traitement médicamenteux), Insuffisance rénale chronique (), Insuffisance rénale chronique (mortalité), Maladie des artères coronaires (), Maladie des artères coronaires (mortalité), Mâle, Résultat thérapeutique, Sujet âgé, Thrombose coronarienne (), Thrombose coronarienne (mortalité).
- MESH :
- administration et posologie : Adénosine, Antagonistes des récepteurs purinergiques P2Y.
- analogues et dérivés : Adénosine.
- effets indésirables : Adénosine, Antagonistes des récepteurs purinergiques P2Y.
- mortalité : Infarctus du myocarde, Insuffisance rénale chronique, Maladie des artères coronaires, Thrombose coronarienne.
- traitement médicamenteux : Infarctus du myocarde.
- Adulte d'âge moyen, Calendrier d'administration des médicaments, Estimation de Kaplan-Meier, Facteurs de risque, Femelle, Humains, Hémorragie, Insuffisance rénale chronique, Maladie des artères coronaires, Mâle, Résultat thérapeutique, Sujet âgé, Thrombose coronarienne.
English descriptors
- KwdEn :
- Adenosine (administration & dosage), Adenosine (adverse effects), Adenosine (analogs & derivatives), Aged, Coronary Artery Disease (mortality), Coronary Artery Disease (prevention & control), Coronary Thrombosis (mortality), Coronary Thrombosis (prevention & control), Drug Administration Schedule, Female, Hemorrhage (chemically induced), Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Infarction (drug therapy), Myocardial Infarction (mortality), Purinergic P2Y Receptor Antagonists (administration & dosage), Purinergic P2Y Receptor Antagonists (adverse effects), Renal Insufficiency, Chronic (complications), Renal Insufficiency, Chronic (mortality), Risk Factors, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Adenosine, Purinergic P2Y Receptor Antagonists.
- chemical , adverse effects : Adenosine, Purinergic P2Y Receptor Antagonists.
- chemical , analogs & derivatives : Adenosine.
- chemically induced : Hemorrhage.
- complications : Renal Insufficiency, Chronic.
- drug therapy : Myocardial Infarction.
- mortality : Coronary Artery Disease, Coronary Thrombosis, Myocardial Infarction, Renal Insufficiency, Chronic.
- prevention & control : Coronary Artery Disease, Coronary Thrombosis.
- Aged, Drug Administration Schedule, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Risk Factors, Treatment Outcome.
Abstract
We evaluated the relationship of renal function and ischaemic and bleeding risk as well as the efficacy and safety of ticagrelor in stable patients with prior myocardial infarction (MI).
DOI: 10.1093/eurheartj/ehv482
PubMed: 26443023
Affiliations:
- Australie, Bulgarie, Chili, Colombie, France, Italie, Norvège, Pérou, Royaume-Uni, Serbie, Suède, Ukraine, États-Unis
- Massachusetts, Sofia-ville (oblast), État de New York, Île-de-France
- Paris, Sofia
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002546
- to stream PubMed, to step Curation: 002478
- to stream PubMed, to step Checkpoint: 002478
- to stream Ncbi, to step Merge: 002B86
- to stream Ncbi, to step Curation: 002B86
- to stream Ncbi, to step Checkpoint: 002B86
- to stream Main, to step Merge: 002010
- to stream Main, to step Curation: 002011
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.</title><author><name sortKey="Magnani, Giulia" sort="Magnani, Giulia" uniqKey="Magnani G" first="Giulia" last="Magnani">Giulia Magnani</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Storey, Robert F" sort="Storey, Robert F" uniqKey="Storey R" first="Robert F" last="Storey">Robert F. Storey</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Cardiovascular Science, University of Sheffield, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Steg, Gabriel" sort="Steg, Gabriel" uniqKey="Steg G" first="Gabriel" last="Steg">Gabriel Steg</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, DHU-FIRE, Hôpital Bichat, Paris, France Université Paris-Diderot, Paris, France INSERM U1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Cardiology Department, DHU-FIRE, Hôpital Bichat, Paris, France Université Paris-Diderot, Paris, France INSERM U1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bhatt, Deepak L" sort="Bhatt, Deepak L" uniqKey="Bhatt D" first="Deepak L" last="Bhatt">Deepak L. Bhatt</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cohen, Marc" sort="Cohen, Marc" uniqKey="Cohen M" first="Marc" last="Cohen">Marc Cohen</name><affiliation wicri:level="2"><nlm:affiliation>Cardiovascular Division, Department of Medicine, Rutgers-New Jersey Medical School, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cardiovascular Division, Department of Medicine, Rutgers-New Jersey Medical School, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Kuder, Julia" sort="Kuder, Julia" uniqKey="Kuder J" first="Julia" last="Kuder">Julia Kuder</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Im, Kyungah" sort="Im, Kyungah" uniqKey="Im K" first="Kyungah" last="Im">Kyungah Im</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name><affiliation wicri:level="1"><nlm:affiliation>Division of Medicine, Cardiac & Critical Care Services, Flinders University and Medical Centre, Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Division of Medicine, Cardiac & Critical Care Services, Flinders University and Medical Centre, Adelaide</wicri:regionArea><wicri:noRegion>Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Ardissino, Diego" sort="Ardissino, Diego" uniqKey="Ardissino D" first="Diego" last="Ardissino">Diego Ardissino</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Division, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Cardiovascular Division, Azienda Ospedaliero-Universitaria di Parma, Parma</wicri:regionArea><wicri:noRegion>Parma</wicri:noRegion></affiliation></author><author><name sortKey="Isaza, Daniel" sort="Isaza, Daniel" uniqKey="Isaza D" first="Daniel" last="Isaza">Daniel Isaza</name><affiliation wicri:level="1"><nlm:affiliation>Fundacion CardioInfantil, Bogota, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Fundacion CardioInfantil, Bogota</wicri:regionArea><wicri:noRegion>Bogota</wicri:noRegion></affiliation></author><author><name sortKey="Parkhomenko, Alexander" sort="Parkhomenko, Alexander" uniqKey="Parkhomenko A" first="Alexander" last="Parkhomenko">Alexander Parkhomenko</name><affiliation wicri:level="1"><nlm:affiliation>Ukranian Strazhesko Institute of Cardiology, Kiev, Ukraine.</nlm:affiliation><country xml:lang="fr">Ukraine</country><wicri:regionArea>Ukranian Strazhesko Institute of Cardiology, Kiev</wicri:regionArea><wicri:noRegion>Kiev</wicri:noRegion></affiliation></author><author><name sortKey="Goudev, Assen R" sort="Goudev, Assen R" uniqKey="Goudev A" first="Assen R" last="Goudev">Assen R. Goudev</name><affiliation wicri:level="3"><nlm:affiliation>Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria.</nlm:affiliation><country xml:lang="fr">Bulgarie</country><wicri:regionArea>Department of Cardiology, Queen Giovanna University Hospital, Sofia</wicri:regionArea><placeName><settlement type="city">Sofia</settlement><region nuts="2">Sofia-ville (oblast)</region></placeName></affiliation></author><author><name sortKey="Dellborg, Mikael" sort="Dellborg, Mikael" uniqKey="Dellborg M" first="Mikael" last="Dellborg">Mikael Dellborg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg</wicri:regionArea><wicri:noRegion>Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Kontny, Frederic" sort="Kontny, Frederic" uniqKey="Kontny F" first="Frederic" last="Kontny">Frederic Kontny</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Cardiology, Stavanger University Hospital, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Corbalan, Ramon" sort="Corbalan, Ramon" uniqKey="Corbalan R" first="Ramon" last="Corbalan">Ramon Corbalan</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago</wicri:regionArea><wicri:noRegion>Santiago</wicri:noRegion></affiliation></author><author><name sortKey="Medina, Felix" sort="Medina, Felix" uniqKey="Medina F" first="Felix" last="Medina">Felix Medina</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima, Peru.</nlm:affiliation><country xml:lang="fr">Pérou</country><wicri:regionArea>Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima</wicri:regionArea><wicri:noRegion>Lima</wicri:noRegion></affiliation></author><author><name sortKey="Jensen, Eva C" sort="Jensen, Eva C" uniqKey="Jensen E" first="Eva C" last="Jensen">Eva C. Jensen</name><affiliation wicri:level="1"><nlm:affiliation>AstraZenecaAZ R&D, Molndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZenecaAZ R&D, Molndal</wicri:regionArea><wicri:noRegion>Molndal</wicri:noRegion></affiliation></author><author><name sortKey="Held, Peter" sort="Held, Peter" uniqKey="Held P" first="Peter" last="Held">Peter Held</name><affiliation wicri:level="1"><nlm:affiliation>AstraZenecaAZ R&D, Molndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZenecaAZ R&D, Molndal</wicri:regionArea><wicri:noRegion>Molndal</wicri:noRegion></affiliation></author><author><name sortKey="Braunwald, Eugene" sort="Braunwald, Eugene" uniqKey="Braunwald E" first="Eugene" last="Braunwald">Eugene Braunwald</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sabatine, Marc S" sort="Sabatine, Marc S" uniqKey="Sabatine M" first="Marc S" last="Sabatine">Marc S. Sabatine</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Bonaca, Marc P" sort="Bonaca, Marc P" uniqKey="Bonaca M" first="Marc P" last="Bonaca">Marc P. Bonaca</name><affiliation wicri:level="1"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA mbonaca@partners.org.</nlm:affiliation><country wicri:rule="url">Serbie</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><wicri:noRegion>MA</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26443023</idno><idno type="pmid">26443023</idno><idno type="doi">10.1093/eurheartj/ehv482</idno><idno type="wicri:Area/PubMed/Corpus">002546</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002546</idno><idno type="wicri:Area/PubMed/Curation">002478</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002478</idno><idno type="wicri:Area/PubMed/Checkpoint">002478</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002478</idno><idno type="wicri:Area/Ncbi/Merge">002B86</idno><idno type="wicri:Area/Ncbi/Curation">002B86</idno><idno type="wicri:Area/Ncbi/Checkpoint">002B86</idno><idno type="wicri:Area/Main/Merge">002010</idno><idno type="wicri:Area/Main/Curation">002011</idno><idno type="wicri:Area/Main/Exploration">002011</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.</title><author><name sortKey="Magnani, Giulia" sort="Magnani, Giulia" uniqKey="Magnani G" first="Giulia" last="Magnani">Giulia Magnani</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Storey, Robert F" sort="Storey, Robert F" uniqKey="Storey R" first="Robert F" last="Storey">Robert F. Storey</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Cardiovascular Science, University of Sheffield, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Steg, Gabriel" sort="Steg, Gabriel" uniqKey="Steg G" first="Gabriel" last="Steg">Gabriel Steg</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, DHU-FIRE, Hôpital Bichat, Paris, France Université Paris-Diderot, Paris, France INSERM U1148, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Cardiology Department, DHU-FIRE, Hôpital Bichat, Paris, France Université Paris-Diderot, Paris, France INSERM U1148, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bhatt, Deepak L" sort="Bhatt, Deepak L" uniqKey="Bhatt D" first="Deepak L" last="Bhatt">Deepak L. Bhatt</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Cohen, Marc" sort="Cohen, Marc" uniqKey="Cohen M" first="Marc" last="Cohen">Marc Cohen</name><affiliation wicri:level="2"><nlm:affiliation>Cardiovascular Division, Department of Medicine, Rutgers-New Jersey Medical School, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cardiovascular Division, Department of Medicine, Rutgers-New Jersey Medical School, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Kuder, Julia" sort="Kuder, Julia" uniqKey="Kuder J" first="Julia" last="Kuder">Julia Kuder</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Im, Kyungah" sort="Im, Kyungah" uniqKey="Im K" first="Kyungah" last="Im">Kyungah Im</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name><affiliation wicri:level="1"><nlm:affiliation>Division of Medicine, Cardiac & Critical Care Services, Flinders University and Medical Centre, Adelaide, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Division of Medicine, Cardiac & Critical Care Services, Flinders University and Medical Centre, Adelaide</wicri:regionArea><wicri:noRegion>Adelaide</wicri:noRegion></affiliation></author><author><name sortKey="Ardissino, Diego" sort="Ardissino, Diego" uniqKey="Ardissino D" first="Diego" last="Ardissino">Diego Ardissino</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Division, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Cardiovascular Division, Azienda Ospedaliero-Universitaria di Parma, Parma</wicri:regionArea><wicri:noRegion>Parma</wicri:noRegion></affiliation></author><author><name sortKey="Isaza, Daniel" sort="Isaza, Daniel" uniqKey="Isaza D" first="Daniel" last="Isaza">Daniel Isaza</name><affiliation wicri:level="1"><nlm:affiliation>Fundacion CardioInfantil, Bogota, Colombia.</nlm:affiliation><country xml:lang="fr">Colombie</country><wicri:regionArea>Fundacion CardioInfantil, Bogota</wicri:regionArea><wicri:noRegion>Bogota</wicri:noRegion></affiliation></author><author><name sortKey="Parkhomenko, Alexander" sort="Parkhomenko, Alexander" uniqKey="Parkhomenko A" first="Alexander" last="Parkhomenko">Alexander Parkhomenko</name><affiliation wicri:level="1"><nlm:affiliation>Ukranian Strazhesko Institute of Cardiology, Kiev, Ukraine.</nlm:affiliation><country xml:lang="fr">Ukraine</country><wicri:regionArea>Ukranian Strazhesko Institute of Cardiology, Kiev</wicri:regionArea><wicri:noRegion>Kiev</wicri:noRegion></affiliation></author><author><name sortKey="Goudev, Assen R" sort="Goudev, Assen R" uniqKey="Goudev A" first="Assen R" last="Goudev">Assen R. Goudev</name><affiliation wicri:level="3"><nlm:affiliation>Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria.</nlm:affiliation><country xml:lang="fr">Bulgarie</country><wicri:regionArea>Department of Cardiology, Queen Giovanna University Hospital, Sofia</wicri:regionArea><placeName><settlement type="city">Sofia</settlement><region nuts="2">Sofia-ville (oblast)</region></placeName></affiliation></author><author><name sortKey="Dellborg, Mikael" sort="Dellborg, Mikael" uniqKey="Dellborg M" first="Mikael" last="Dellborg">Mikael Dellborg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg</wicri:regionArea><wicri:noRegion>Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Kontny, Frederic" sort="Kontny, Frederic" uniqKey="Kontny F" first="Frederic" last="Kontny">Frederic Kontny</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.</nlm:affiliation><country xml:lang="fr">Norvège</country><wicri:regionArea>Department of Cardiology, Stavanger University Hospital, Stavanger</wicri:regionArea><wicri:noRegion>Stavanger</wicri:noRegion></affiliation></author><author><name sortKey="Corbalan, Ramon" sort="Corbalan, Ramon" uniqKey="Corbalan R" first="Ramon" last="Corbalan">Ramon Corbalan</name><affiliation wicri:level="1"><nlm:affiliation>Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago, Chile.</nlm:affiliation><country xml:lang="fr">Chili</country><wicri:regionArea>Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago</wicri:regionArea><wicri:noRegion>Santiago</wicri:noRegion></affiliation></author><author><name sortKey="Medina, Felix" sort="Medina, Felix" uniqKey="Medina F" first="Felix" last="Medina">Felix Medina</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima, Peru.</nlm:affiliation><country xml:lang="fr">Pérou</country><wicri:regionArea>Hospital Nacional Cayetano Heredia, San Martin de Porres, Lima</wicri:regionArea><wicri:noRegion>Lima</wicri:noRegion></affiliation></author><author><name sortKey="Jensen, Eva C" sort="Jensen, Eva C" uniqKey="Jensen E" first="Eva C" last="Jensen">Eva C. Jensen</name><affiliation wicri:level="1"><nlm:affiliation>AstraZenecaAZ R&D, Molndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZenecaAZ R&D, Molndal</wicri:regionArea><wicri:noRegion>Molndal</wicri:noRegion></affiliation></author><author><name sortKey="Held, Peter" sort="Held, Peter" uniqKey="Held P" first="Peter" last="Held">Peter Held</name><affiliation wicri:level="1"><nlm:affiliation>AstraZenecaAZ R&D, Molndal, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>AstraZenecaAZ R&D, Molndal</wicri:regionArea><wicri:noRegion>Molndal</wicri:noRegion></affiliation></author><author><name sortKey="Braunwald, Eugene" sort="Braunwald, Eugene" uniqKey="Braunwald E" first="Eugene" last="Braunwald">Eugene Braunwald</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sabatine, Marc S" sort="Sabatine, Marc S" uniqKey="Sabatine M" first="Marc S" last="Sabatine">Marc S. Sabatine</name><affiliation wicri:level="2"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Bonaca, Marc P" sort="Bonaca, Marc P" uniqKey="Bonaca M" first="Marc P" last="Bonaca">Marc P. Bonaca</name><affiliation wicri:level="1"><nlm:affiliation>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, USA mbonaca@partners.org.</nlm:affiliation><country wicri:rule="url">Serbie</country><wicri:regionArea>TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA</wicri:regionArea><wicri:noRegion>MA</wicri:noRegion></affiliation></author></analytic><series><title level="j">European heart journal</title><idno type="eISSN">1522-9645</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine (administration & dosage)</term><term>Adenosine (adverse effects)</term><term>Adenosine (analogs & derivatives)</term><term>Aged</term><term>Coronary Artery Disease (mortality)</term><term>Coronary Artery Disease (prevention & control)</term><term>Coronary Thrombosis (mortality)</term><term>Coronary Thrombosis (prevention & control)</term><term>Drug Administration Schedule</term><term>Female</term><term>Hemorrhage (chemically induced)</term><term>Humans</term><term>Kaplan-Meier Estimate</term><term>Male</term><term>Middle Aged</term><term>Myocardial Infarction (drug therapy)</term><term>Myocardial Infarction (mortality)</term><term>Purinergic P2Y Receptor Antagonists (administration & dosage)</term><term>Purinergic P2Y Receptor Antagonists (adverse effects)</term><term>Renal Insufficiency, Chronic (complications)</term><term>Renal Insufficiency, Chronic (mortality)</term><term>Risk Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Adénosine (administration et posologie)</term><term>Adénosine (analogues et dérivés)</term><term>Adénosine (effets indésirables)</term><term>Antagonistes des récepteurs purinergiques P2Y (administration et posologie)</term><term>Antagonistes des récepteurs purinergiques P2Y (effets indésirables)</term><term>Calendrier d'administration des médicaments</term><term>Estimation de Kaplan-Meier</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hémorragie ()</term><term>Infarctus du myocarde (mortalité)</term><term>Infarctus du myocarde (traitement médicamenteux)</term><term>Insuffisance rénale chronique ()</term><term>Insuffisance rénale chronique (mortalité)</term><term>Maladie des artères coronaires ()</term><term>Maladie des artères coronaires (mortalité)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Thrombose coronarienne ()</term><term>Thrombose coronarienne (mortalité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adenosine</term><term>Purinergic P2Y Receptor Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adenosine</term><term>Purinergic P2Y Receptor Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Adénosine</term><term>Antagonistes des récepteurs purinergiques P2Y</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Adénosine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hemorrhage</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Adénosine</term><term>Antagonistes des récepteurs purinergiques P2Y</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronary Artery Disease</term><term>Coronary Thrombosis</term><term>Myocardial Infarction</term><term>Renal Insufficiency, Chronic</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infarctus du myocarde</term><term>Insuffisance rénale chronique</term><term>Maladie des artères coronaires</term><term>Thrombose coronarienne</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronary Artery Disease</term><term>Coronary Thrombosis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infarctus du myocarde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Drug Administration Schedule</term><term>Female</term><term>Humans</term><term>Kaplan-Meier Estimate</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Calendrier d'administration des médicaments</term><term>Estimation de Kaplan-Meier</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hémorragie</term><term>Insuffisance rénale chronique</term><term>Maladie des artères coronaires</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Thrombose coronarienne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We evaluated the relationship of renal function and ischaemic and bleeding risk as well as the efficacy and safety of ticagrelor in stable patients with prior myocardial infarction (MI).</div></front></TEI><affiliations><list><country><li>Australie</li><li>Bulgarie</li><li>Chili</li><li>Colombie</li><li>France</li><li>Italie</li><li>Norvège</li><li>Pérou</li><li>Royaume-Uni</li><li>Serbie</li><li>Suède</li><li>Ukraine</li><li>États-Unis</li></country><region><li>Massachusetts</li><li>Sofia-ville (oblast)</li><li>État de New York</li><li>Île-de-France</li></region><settlement><li>Paris</li><li>Sofia</li></settlement></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Magnani, Giulia" sort="Magnani, Giulia" uniqKey="Magnani G" first="Giulia" last="Magnani">Giulia Magnani</name></region><name sortKey="Bhatt, Deepak L" sort="Bhatt, Deepak L" uniqKey="Bhatt D" first="Deepak L" last="Bhatt">Deepak L. Bhatt</name><name sortKey="Braunwald, Eugene" sort="Braunwald, Eugene" uniqKey="Braunwald E" first="Eugene" last="Braunwald">Eugene Braunwald</name><name sortKey="Cohen, Marc" sort="Cohen, Marc" uniqKey="Cohen M" first="Marc" last="Cohen">Marc Cohen</name><name sortKey="Im, Kyungah" sort="Im, Kyungah" uniqKey="Im K" first="Kyungah" last="Im">Kyungah Im</name><name sortKey="Kuder, Julia" sort="Kuder, Julia" uniqKey="Kuder J" first="Julia" last="Kuder">Julia Kuder</name><name sortKey="Sabatine, Marc S" sort="Sabatine, Marc S" uniqKey="Sabatine M" first="Marc S" last="Sabatine">Marc S. Sabatine</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Storey, Robert F" sort="Storey, Robert F" uniqKey="Storey R" first="Robert F" last="Storey">Robert F. Storey</name></noRegion></country><country name="France"><region name="Île-de-France"><name sortKey="Steg, Gabriel" sort="Steg, Gabriel" uniqKey="Steg G" first="Gabriel" last="Steg">Gabriel Steg</name></region></country><country name="Australie"><noRegion><name sortKey="Aylward, Philip" sort="Aylward, Philip" uniqKey="Aylward P" first="Philip" last="Aylward">Philip Aylward</name></noRegion></country><country name="Italie"><noRegion><name sortKey="Ardissino, Diego" sort="Ardissino, Diego" uniqKey="Ardissino D" first="Diego" last="Ardissino">Diego Ardissino</name></noRegion></country><country name="Colombie"><noRegion><name sortKey="Isaza, Daniel" sort="Isaza, Daniel" uniqKey="Isaza D" first="Daniel" last="Isaza">Daniel Isaza</name></noRegion></country><country name="Ukraine"><noRegion><name sortKey="Parkhomenko, Alexander" sort="Parkhomenko, Alexander" uniqKey="Parkhomenko A" first="Alexander" last="Parkhomenko">Alexander Parkhomenko</name></noRegion></country><country name="Bulgarie"><region name="Sofia-ville (oblast)"><name sortKey="Goudev, Assen R" sort="Goudev, Assen R" uniqKey="Goudev A" first="Assen R" last="Goudev">Assen R. Goudev</name></region></country><country name="Suède"><noRegion><name sortKey="Dellborg, Mikael" sort="Dellborg, Mikael" uniqKey="Dellborg M" first="Mikael" last="Dellborg">Mikael Dellborg</name></noRegion><name sortKey="Held, Peter" sort="Held, Peter" uniqKey="Held P" first="Peter" last="Held">Peter Held</name><name sortKey="Jensen, Eva C" sort="Jensen, Eva C" uniqKey="Jensen E" first="Eva C" last="Jensen">Eva C. Jensen</name></country><country name="Norvège"><noRegion><name sortKey="Kontny, Frederic" sort="Kontny, Frederic" uniqKey="Kontny F" first="Frederic" last="Kontny">Frederic Kontny</name></noRegion></country><country name="Chili"><noRegion><name sortKey="Corbalan, Ramon" sort="Corbalan, Ramon" uniqKey="Corbalan R" first="Ramon" last="Corbalan">Ramon Corbalan</name></noRegion></country><country name="Pérou"><noRegion><name sortKey="Medina, Felix" sort="Medina, Felix" uniqKey="Medina F" first="Felix" last="Medina">Felix Medina</name></noRegion></country><country name="Serbie"><noRegion><name sortKey="Bonaca, Marc P" sort="Bonaca, Marc P" uniqKey="Bonaca M" first="Marc P" last="Bonaca">Marc P. Bonaca</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002011 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002011 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26443023
|texte= Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26443023" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |